These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6142519)

  • 1. [Buccofacial dyskinesia of iatrogenic origin].
    Reynes P; Guichard M; Guiraud P
    Rev Odontostomatol (Paris); 1983; 12(6):461-9. PubMed ID: 6142519
    [No Abstract]   [Full Text] [Related]  

  • 2. Tardive dyskinesia and pseudo-parkinsonism. In a nursing home patient who itched.
    Ondo WG; Hurwitz BJ
    N C Med J; 1993 Nov; 54(11):605-7. PubMed ID: 8272117
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinematic analysis of handwriting movements in schizophrenic patients.
    Gallucci RM; Phillips JG; Bradshaw JL; Vaddadi KS; Pantelis C
    Biol Psychiatry; 1997 Apr; 41(7):830-3. PubMed ID: 9084903
    [No Abstract]   [Full Text] [Related]  

  • 4. Portable device for quantifying parkinsonian wrist rigidity.
    Caligiuri MP
    Mov Disord; 1994 Jan; 9(1):57-63. PubMed ID: 7908119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic-induced extrapyramidal reactions: classification, description, and diagnosis.
    Tarsy D
    Clin Neuropharmacol; 1983; 6 Suppl 1():S9-26. PubMed ID: 6139168
    [No Abstract]   [Full Text] [Related]  

  • 7. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tardive dyskinesias].
    Mignot G
    Encephale; 1983; 9(2):151-66. PubMed ID: 6139271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cases of abnormal movements].
    Singer B
    Sem Hop; 1979 Jan 8-15; 55(1-2):83-4. PubMed ID: 34219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys.
    Bédard PJ; Gomez-Mancilla B; Blanchette P; Gagnon C; Falardeau P; DiPaolo T
    Adv Neurol; 1993; 60():113-8. PubMed ID: 8093573
    [No Abstract]   [Full Text] [Related]  

  • 11. Meige's syndrome or tardive dyskinesia?
    Dilsaver SC; Domino L; Greden JF
    J Clin Psychopharmacol; 1985 Dec; 5(6):362-4. PubMed ID: 2866201
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in the biochemical pharmacology of extrapyramidal movement disorders.
    Klawans HL; Goetz C; Nausieda PA; Weiner WJ
    Adv Exp Med Biol; 1977; 90():21-47. PubMed ID: 145167
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
    Visanji NP; Gomez-Ramirez J; Johnston TH; Pires D; Voon V; Brotchie JM; Fox SH
    Mov Disord; 2006 Nov; 21(11):1879-91. PubMed ID: 16960862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics.
    Kulik FA; Wilbur R
    Psychopharmacol Bull; 1980 Jul; 16(3):18-9. PubMed ID: 6105690
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in understanding the neural mechanisms underlying L-DOPA-induced dyskinesia.
    Brotchie JM
    Adv Neurol; 1999; 80():71-85. PubMed ID: 10410705
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
    Trosch RM
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S266-71. PubMed ID: 15541167
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias.
    Delfino MA; Stefano AV; Ferrario JE; Taravini IR; Murer MG; Gershanik OS
    Behav Brain Res; 2004 Jul; 152(2):297-306. PubMed ID: 15196797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
    Manson AJ; Turner K; Lees AJ
    Mov Disord; 2002 Nov; 17(6):1235-41. PubMed ID: 12465062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate receptor-mediated mechanisms in levodopa-induced motor fluctuations in an experimental model of parkinsonism.
    Marin C; Tolosa E
    Adv Neurol; 1999; 80():129-33. PubMed ID: 10410712
    [No Abstract]   [Full Text] [Related]  

  • 20. Punding and dyskinesias.
    Silveira-Moriyama L; Evans AH; Katzenschlager R; Lees AJ
    Mov Disord; 2006 Dec; 21(12):2214-7. PubMed ID: 17013916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.